Difference between revisions of "PRAME"

From Libre Pathology
Jump to navigation Jump to search
 
(One intermediate revision by the same user not shown)
Line 18: Line 18:


[[Category:Immunohistochemistry]]
[[Category:Immunohistochemistry]]
[[Category: Abbreviation]]

Latest revision as of 21:23, 4 March 2025

PRAME is an immunostain that is typically positive in malignant melanoma.[1]

General

  • PRAME is an acronym for PReferentially expressed Antigen in MElanoma.

Positive staining

  • 80-85% of primary melanomas.[1]
  • 85-90% of metastatic melanomas.[1]

Pattern:[2]

  • Nuclear staining.

See also

References

  1. ↑ Jump up to: 1.0 1.1 1.2 Lezcano C, Jungbluth AA, Nehal KS, Hollmann TJ, Busam KJ (November 2018). "PRAME Expression in Melanocytic Tumors". Am J Surg Pathol 42 (11): 1456–1465. doi:10.1097/PAS.0000000000001134. PMC 6631376. PMID 30045064. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631376/.
  2. ↑ Lezcano C, Jungbluth AA, Busam KJ (June 2021). "PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions". Surg Pathol Clin 14 (2): 165–175. doi:10.1016/j.path.2021.01.001. PMC 8152939. PMID 34023098. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152939/.
Retrieved from "https://librepathology.org/w/index.php?title=PRAME&oldid=53457"